Tower Research Capital LLC (Trc) Regenxbio Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Regenxbio Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,246 shares of RGNX stock, worth $23,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,246

Previous 13,077 82.82%

Holding current value

$23,874

Previous $234,000 79.91%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $131,813 - $266,550	-10,831 Reduced 82.82%	2,246 $47,000
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $108,778 - $175,699	8,439 Added 181.95%	13,077 $234,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $50,466 - $61,289	3,066 Added 195.04%	4,638 $76,000
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $172 - $217	-10 Reduced 0.63%	1,572 $31,000
Q1 2023 May 09, 2023	SELL	$18.08 - $24.55 $86,964 - $118,085	-4,810 Reduced 75.25%	1,582 $30,000

Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $8,404 - $10,188	412 Added 6.89%	6,392 $145,000
Q3 2022 Nov 10, 2022	BUY	$22.29 - $35.04 $2,607 - $4,099	117 Added 2.0%	5,980 $158,000
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $40,170 - $72,743	-2,076 Reduced 26.15%	5,863 $145,000
Q1 2022 May 12, 2022	BUY	$24.62 - $34.31 $16,938 - $23,605	688 Added 9.49%	7,939 $264,000
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $12,770 - $17,038	-423 Reduced 5.51%	7,251 $237,000
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $138,032 - $216,751	4,745 Added 162.0%	7,674 $321,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $5,972 - $7,448	184 Added 6.7%	2,929 $113,000
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $36,298 - $53,946	1,080 Added 64.86%	2,745 $93,000
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $3,394 - $6,316	-128 Reduced 7.14%	1,665 $76,000
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $121,869 - $181,653	-4,512 Reduced 71.56%	1,793 $49,000
Q2 2020 Aug 13, 2020	BUY	$27.75 - $43.44 $80,586 - $126,149	2,904 Added 85.39%	6,305 $232,000
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $20,984 - $52,899	976 Added 40.25%	3,401 $110,000
Q4 2019 Feb 07, 2020	BUY	$34.54 - $44.87 $83,759 - $108,809	2,425 New	2,425 $99,000
Q2 2019 Aug 13, 2019	SELL	$42.0 - $59.29 $3,066 - $4,328	-73 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $2,979 - $4,558	73 New	73 $4,000
Q4 2018 Feb 14, 2019	SELL	$39.11 - $75.15 $10,598 - $20,365	-271 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $17,615 - $22,262	271 New	271 $20,000
Q2 2018 Aug 15, 2018	SELL	$27.2 - $74.35 $20,563 - $56,208	-756 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$24.05 - $37.5 $4,954 - $7,725	206 Added 37.45%	756 $23,000
Q4 2017 Feb 09, 2018	SELL	$26.0 - $34.6 $8,658 - $11,521	-333 Reduced 37.71%	550 $18,000
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $15,894 - $29,094	883	883 $29,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Regenxbio Inc. Transaction History